Compare TAYD & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAYD | PRE |
|---|---|---|
| Founded | 1955 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.1M | 131.3M |
| IPO Year | N/A | N/A |
| Metric | TAYD | PRE |
|---|---|---|
| Price | $58.88 | $17.32 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 6.1K | ★ 144.7K |
| Earning Date | 01-05-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.72 | N/A |
| Revenue | $44,593,219.00 | ★ $77,079,000.00 |
| Revenue This Year | $10.81 | $219.28 |
| Revenue Next Year | $8.37 | $124.38 |
| P/E Ratio | $20.97 | ★ N/A |
| Revenue Growth | N/A | ★ 201.54 |
| 52 Week Low | $29.50 | $3.10 |
| 52 Week High | $59.74 | $17.99 |
| Indicator | TAYD | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 74.05 | 65.36 |
| Support Level | $55.32 | $14.02 |
| Resistance Level | $52.00 | $17.00 |
| Average True Range (ATR) | 2.34 | 1.19 |
| MACD | 0.93 | 0.28 |
| Stochastic Oscillator | 92.96 | 96.27 |
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.